(Q30817229)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909305%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909305%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909305%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Damiano Paolicelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909305%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Paolo Livrea

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909305%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Maria Trojano

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909305%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

C Avolio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909305%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

F Giuliani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909305%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Ruggieri

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909305%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

P Riccio

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909305%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 August 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909305%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

published in

Brain Research Bulletin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909305%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909305%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909305%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

357-364

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909305%20AND%20SRC:MED&resulttype=core&format=json

Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS.

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

LFA-1 expression on CD4(+)CD45RO(+) peripheral blood T-lymphocytes in RR MS: effects induced by rIFNbeta-1a.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Molecular pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

T lymphocytes conditioned with Interferon beta induce membrane and soluble VCAM on human brain endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Microglial production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferonbeta-1b

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Matrix metalloproteinases degrade myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Human T lymphocytes express a member of the Matrix Metalloproteinase gene family

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Effects of beta-IFN-1b treatment in MS patients on adhesion between PBMNCs, HUVECs and MS-HBECs: an in vivo and in vitro study.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

ICAM 1 expression and fluid phase endocytosis of cultured brain microvascular endothelial cells following exposure to interferon beta-1a and TNFalpha

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

A comparative study of the relative bioavailability of different interferon beta preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

The effect of interferon beta-1b on lymphocyte-endothelial cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Serum endothelial adhesion molecules levels correlate with lesion burden in multiple sclerosis patients treated with interferon beta-1b

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Immunological effects of in vivo interferon-beta1b treatment in ten patients with multiple sclerosis: a 1-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: implications for angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Biology of tumor cell invasion: interplay of cell adhesion and matrix degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Interferon response heterogeneity: activation of a pro-inflammatory response by interferon alpha and beta. A possible basis for diverse responses to interferon beta in MS

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

The effect of interferon beta-1b on cytokine-induced adhesion molecule expression

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Cytokine-induced modulation of cellular adhesion to human cerebral endothelial cells is mediated by soluble vascular cell adhesion molecule-1

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Matrix metalloproteinases in inflammatory demyelination: targets for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Antibodies against leukocyte function-associated antigen-1 and against intercellular adhesion molecule-1 together suppress the progression of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Integrin leukocyte function-associated antigen-1-mediated cell binding can be activated by clustering of membrane rafts

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Magnetic resonance imaging results of the PRISMS trial: a randomized, double-blind, placebo-controlled study of interferon-beta1a in relapsing-remitting multiple sclerosis. Prevention of Relapses and Disability by Interferon-beta1a Subcutaneously in

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Cleavage of membrane-associated ICAM-1 from astrocytes: involvement of a metalloprotease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Influence of IFN-beta1b (Betaferon) on cytokine mRNA profiles in blood mononuclear cells and plasma levels of soluble VCAM-1 in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Immunoregulatory effects of interferon-beta and interacting cytokines on human vascular endothelial cells. Implications for multiple sclerosis autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Partial inhibition of AT-EAE by an antibody to ICAM-1: clinico-histological and MRI studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Regulation of matrix metalloproteinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Active and tissue inhibitor of matrix metalloproteinase-free gelatinase B accumulates within human microvascular endothelial vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Immunomodulatory effects of interferon-beta-1b in vivo: induction of the expression of transforming growth factor-beta1 and its receptor type II

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Metalloproteinases and their tissue inhibitors in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Interferon-beta interferes with the proliferation but not with the cytokine secretion of myelin basic protein-specific, T-helper type 1 lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Leukocyte Gelatinase B Cleavage Releases Encephalitogens from Human Myelin Basic Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Cerebral endothelial cells are a major source for soluble intercellular adhesion molecule-1 in the human central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: an indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Differential effects of beta and gamma interferons on expression of major histocompatibility complex antigens and intercellular adhesion molecule-1 in cultured fetal human astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP).

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Therapy with antibody against leukocyte integrin VLA-4 (CD49d) is effective and safe in virus-facilitated experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Interferon-beta downregulates expression of VLA-4 antigen and antagonizes interferon-gamma-induced expression of HLA-DQ on human peripheral blood monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Changes of serum sICAM-1 and MMP-9 induced by rIFN -1b treatment in relapsing-remitting MS

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Serum soluble intercellular adhesion molecule-I in MS: relation to clinical and Gd-MRI activity and to rIFN beta-Ib treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Soluble intercellular adhesion molecule-I (sICAM-I) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Migratory behavior of lymphocytes isolated from multiple sclerosis patients: effects of interferon beta-1b therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Avidity regulation of integrins: the driving force in leukocyte adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Interferon beta in the treatment of multiple sclerosis: mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

Matrix metalloproteinases and diseases of the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900098-4

7 January 2021

10.1016/S0361-9230(03)00098-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909305%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference